These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 23082)

  • 21. [Changes in regional hemodynamics in response to blocking of the adrenergic beta receptors].
    Granata L; Caraffa Braga E; Cevese A; Data PG
    Boll Soc Ital Biol Sper; 1970 Feb; 46(4):170-3. PubMed ID: 4396928
    [No Abstract]   [Full Text] [Related]  

  • 22. Beta blockers and renal function: a reappraisal.
    Epstein M; Oster JR
    J Clin Hypertens; 1985 Mar; 1(1):85-99. PubMed ID: 2873206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part I: Respiratory and cardiovascular systems.
    Hirohashi M; Takasuna K; Yamashita N; Tamura K
    Arzneimittelforschung; 1991 Jan; 41(1):9-18. PubMed ID: 1675573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Suppression, by beta-adrenergic receptor blockade, of the sympathomimetic component of dopamine renal action in water-saline depletion].
    Agnoli GC; Cacciari M; Garutti C; Lenzi P
    Boll Soc Ital Biol Sper; 1980 May; 56(9):946-52. PubMed ID: 6108775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of sympathetic blocking agents on the antinatriuresis of reflex renal nerve stimulation.
    Zambraski EJ; Dibona GF; Kaloyanides GJ
    J Pharmacol Exp Ther; 1976 Aug; 198(2):464-72. PubMed ID: 7667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intrinsic sympathomimetic activity and the effects of beta-adrenergic blocking drugs on vulnerability to ventricular fibrillation.
    Raeder EA; Verrier RL; Lown B
    J Am Coll Cardiol; 1983 Jun; 1(6):1442-6. PubMed ID: 6133890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypotensive action of beta-blocking drugs injected into the cerebral ventricle of the rat.
    Wepierre J; Lindenbaum A; Porquet D; Cohen Y
    Arch Int Pharmacodyn Ther; 1978 Mar; 232(1):158-65. PubMed ID: 27151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regional blood flow in canine brain during nicotine infusion: effect of autonomic blocking drugs.
    Crystal GJ; Downey HF; Adkins TP; Bashour FA
    Stroke; 1983; 14(6):941-7. PubMed ID: 6140781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adrenergic vasoconstriction as a cause of inadequate hypotensive response to beta-adrenergic blockade.
    Birkenhäger WH; DeLeeuw PW
    Hypertension; 1983; 5(5 Pt 2):III31-5. PubMed ID: 6138310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of lumbar sympathetic stimulation on the vasculature of bone.
    Tran MA
    Br J Pharmacol; 1980 Nov; 70(3):363-6. PubMed ID: 6108143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-Adrenergic Receptor Blockers in Hypertension: Alive and Well.
    Frishman WH
    Prog Cardiovasc Dis; 2016; 59(3):247-252. PubMed ID: 27984052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic and regional haemodynamic profile of diuretics and alpha- and beta-blockers. A review comparing acute and chronic effects.
    Mimran A; Ducailar G
    Drugs; 1988; 35 Suppl 6():60-9. PubMed ID: 2900131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of beta-blocking drugs on peripheral blood flow in intermittent claudication.
    Smith RS; Warren DJ
    J Cardiovasc Pharmacol; 1982; 4(1):2-4. PubMed ID: 6176794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of dextran upon renal blood flow in normovolemic and hypovolemic animals treated with adrenergic blocking agents.
    Wideman FE; Shumacker HB; Minor TM
    Ann Surg; 1969 Nov; 170(5):731-6. PubMed ID: 5347550
    [No Abstract]   [Full Text] [Related]  

  • 35. Correlation between vasodilator potencies of beta-adrenoceptor blocking drugs and their chemical structures.
    Himori N
    Jpn J Pharmacol; 1980 Apr; 30(2):255-8. PubMed ID: 6109034
    [No Abstract]   [Full Text] [Related]  

  • 36. Beta-adrenoceptor blocking drugs and partial agonist activity. Is it clinically relevant?
    McDevitt DG
    Drugs; 1983 Apr; 25(4):331-8. PubMed ID: 6133735
    [No Abstract]   [Full Text] [Related]  

  • 37. Regional blood flow in anemia.
    Grupp I; Grupp G; Holmes JC; Fowler NO
    J Appl Physiol; 1972 Oct; 33(4):456-61. PubMed ID: 4403910
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of beta-adrenergic receptor blocking drugs on cerebral blood flow.
    Griffith DN; James IM; Newbury PA; Woollard ML
    Br J Clin Pharmacol; 1979 May; 7(5):491-4. PubMed ID: 38822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. beta-Blocker and renal function.
    Jackson DA
    Br Med J; 1979 Apr; 1(6171):1149. PubMed ID: 36200
    [No Abstract]   [Full Text] [Related]  

  • 40. Renal vasodilation in response to coronary artery ligation in the dog.
    Stinson JM; Mootry PJ; Jackson CG; Gates HO; Scott MT
    Clin Exp Pharmacol Physiol; 1976; 3(2):191-4. PubMed ID: 975614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.